The final stages of the projects IDeAl, InSPiRe and asterix conclude with the joint workshop Seventh Framework Programme (FP7) small-population research methods projects and regulatory application hosted by the European Medicines Agency in London. During the workshop, the three projects will have the opportunity to intertwine their research in various in-depth workshops, unify their great thinkers, and reach beyond what has been accomplished so far. The hands-on discussions will provide international representatives of patient organisations, pharmaceutical industry, academic statisticians and clinical trial methodologists, clinical researchers, pharmaceutical industry and regulators with the latest recommendations for small population group trials. As a special highlight, the meeting will be broadcasted on the EMA website and, thus, reach stakeholders from all over the world.

Three projects, Asterix, IDeAl and InSPiRe, have been funded by the EU within the Seventh Framework Programme to develop new methodology on design and analysis of small population clinical trials since 2013. A joint dissemination workshop will be held at the European Medicines Agency on 29 & 30 March 2017.

The aim of the workshop is to translate and promote novel methodologies of all three EU FP7 funded projects into tangible recommendations. This research should advance clinical research and the development of new treatments in small populations, such as in rare diseases, children or targeted therapies for personalized medicine. The results and recommendations for applications will be discussed with international representatives of patient organisations, academic statisticians, clinical trial methodologists, clinical researchers, pharmaceutical industry, HTAs and regulators.

For more details on the meeting and the agenda, visit the EMA website. To register, please contact Isabel Perez.

Please note that the meeting shall be broadcasted online via the EMA webpage (tbc).

It would be great to welcome you at the meeting!